Sectors
CURX
Curanex Pharmaceuticals Inc Common Stock
0.20
157 x 0.16
95 x 0.22
bid
ask
+
0.01
5.08%
09:36 AM
timesize
| Ytd | -38.79% | |
| 1y | -94.96% |
0.20
day range
0.20
0.18
52 week range
9.18
| Open | 0.20 | Prev Close | 0.19 | Low | 0.20 | High | 0.20 | Mkt Cap | 5.74M |
| Vol | 5.38K | Avg Vol | 84.90K | EPS | -0.28 | P/E | -0.72 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.25 | 200-d Avg | 0.38 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 3.18M | ||
| Research and Development Expense | 2.26M | ||
| Selling, General and Administrative Expense | 927.20K | ||
| Operating Income | -3.18M | ||
| Net Income | -3.15M | ||
| Net Income Common Stock | -3.15M | ||
| Net Income Common Stock (USD) | -3.15M | ||
| Consolidated Income | -3.15M | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -3.15M | ||
| Earning Before Interest & Taxes (USD) | -3.15M | ||
| Weighted Average Shares | 28.34M | ||
| Weighted Average Shares Diluted | 28.34M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.02M | ||
| Cash and Equivalents (USD) | 4.02M | ||
| Current Assets | 8.09M | ||
| Property, Plant & Equipment Net | 317.57K | ||
| Total Assets | 8.41M | ||
| Debt Current | 107.09K | ||
| Total Debt | 311.00K | ||
| Current Liabilities | 128.73K | ||
| Debt Non-Current | 203.91K | ||
| Total Liabilities | 332.64K | ||
| Accumulated Retained Earnings (Deficit) | -8.00M | ||
| Shareholders Equity | 8.08M | ||
| Shareholders Equity (USD) | 8.08M | ||
| Assets Non-Current | 317.57K | ||
| Total Debt (USD) | 311.00K | ||
| Liabilities Non-Current | 203.91K | ||
| Trade and Non-Trade Payables | 8.40K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 35.04K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -954.56K | ||
| Net Cash Flow from Operations | -954.56K | ||
| Share Based Compensation | 9.79K | ||